News About: Pharm. Industry
Green Cross to complete vaccine plant in first half
Green Cross Corporation says it aims to complete the construction of the nation's new vaccine factory in Hwasun, South Jeolla Province in the first half of this year, according to its recent information session held a...
Korea opens biotechnology commercialization center
The government-funded Korea Biotechnology Commercialization Center (KBCC) had its opening ceremony in Songdo, Incheon Metropolitan city on April 30.
The KBCC is a growing contract manufacturing organization with a-...
Hanmi to bolster tie-up with CrystalGenomics for new drug developmentHanmi Pharm has forged a strategic alliance with CrystalGenomics, a local bioventure firm, to boost its joint research and development projects for new drugs.
Under the agree...
|
9 leading pharmaceutical firms fared well in first quarter
The nation's nine major domestic pharmaceutical firms made good start in the first quarter of this year despite negative factors surrounding the industry, according to data released by Yakup Shinmoon.
The com...
SK, Yuyu seeking long-term approaches over ginkgo biloba preparations
SK Chemicals and Yuyu Pharm, local leading producers of ginkgo biloba preparations plans to cover the expected loss of sales as patients suffering from tinnitus and dizziness are not reimbursed during treatment taking...
Dong-A's associate wholesalers to face margin falling
Pharmaceutical business sources say Dong-A Pharmaceutical reduced the margin of its associate wholesaler margin up to 1 percent.
Wholesalers are now worried that other pharmaceutical firms will follow the suit fol...
W 60 bil. sibutramine market steams up
The domestic sibutramine market valued at 60 billion won is set to heat up.
Following the country's forerunner Abbott’s Reductil, Hammi is rushing into the game selling its chemically modified sibutramine preparati...
Prices of statin based hyperlipemic medicines to be reduced
The Health Review Insurance Agency says health insurance prices of statin based hyperlipemic agents, such as Pfizer’s Lipitor, will be reduced as a result of evaluating the economic effectiveness of those medicines, e...
30% of people aged 20 or older experience hair loss
28 percent of people in their 20s or older have experienced hair loss, according to a recent survey of 968 people throughout the country, conducted by “C-NEWS,'' an online company.
Of the respondents who have exper...
Release of Xenical generics to be delayed
Pharmaceutical sources say the immediate launching of generic Xenical (orlistat) will take time as a local pharmaceutical firm has denied the launching news.
Recently, a domestic pharmaceutical bulk maker is said t...
